Skandinaviska Enskilda Banken (SEB)’s Insys Therapeutics, Inc. INSY Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-87,500	Closed	-$1.11M	–	753
2017 Q2	$1.11M	Sell	87,500 -215,800	-71%	-$2.55M	0.01%	598
2017 Q1	$3.19M	Sell	303,300 -81,500	-21%	-$868K	0.03%	360
2016 Q4	$3.54M	Buy	384,800 +77,100	+25%	+$871K	0.04%	291
2016 Q3	$3.63M	Sell	307,700 -26,000	-8%	-$395K	0.04%	318
2016 Q2	$4.32M	Buy	333,700 +66,000	+25%	+$962K	0.05%	277
2016 Q1	$4.28M	Buy	267,700 +70,200	+36%	+$1.33M	0.05%	273
2015 Q4	$5.8M	Buy	+197,500	New	+$5.47M	0.08%	199

Other funds holding INSY

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

FHAM

Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s INSY Position: Q3 2017 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Insys Therapeutics, Inc. (INSY) in Q3 2017, closing a stake of 87,500 shares — an estimated $1.11M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in INSY in Q4 2015 and held it in 7 quarters. The position peaked at $5.8M in Q4 2015. 116 funds tracked by Wall St. Rank hold INSY as of Q3 2017.

Skandinaviska Enskilda Banken (SEB) reported no remaining Insys Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 87,500 Insys Therapeutics, Inc. shares in Q3 2017, an estimated $1.11M.
Skandinaviska Enskilda Banken (SEB) first reported a position in Insys Therapeutics, Inc. in Q4 2015 and held it in 7 quarters.
Skandinaviska Enskilda Banken (SEB)'s Insys Therapeutics, Inc. position peaked at $5.8M in Q4 2015.
116 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2017.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2017, filed 13 Nov 2017.